Dogwood Therapeutics, Inc. Preferred Stock, Shares Authorized
Dogwood Therapeutics, Inc. (DWTX) had Preferred Stock, Shares Authorized of 5.00 million shares as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockSharesAuthorized · last filed 2026-08-14
- 2026-06-30: Preferred Stock, Shares Authorized 5.00M shares.
- 2026-06-16: Preferred Stock, Shares Authorized 5.00M shares.
- 2025-09-30: Preferred Stock, Shares Authorized 2.00M shares.
- 2025-03-31: Preferred Stock, Shares Authorized 2.00M shares.
| Period end | Preferred Stock, Shares Authorized |
|---|---|
| 2026-06-30 | 5.00M shares 10-Q · filed 2026-08-14 |
| 2026-06-16 | 5.00M shares 10-Q · filed 2026-08-14 |
| 2025-09-30 | 2.00M shares 10-Q · filed 2026-08-14 |
| 2025-03-31 | 2.00M shares 10-Q · filed 2026-08-14 |
| 2024-12-31 | 2.00M shares 10-K · filed 2025-03-31 |
| 2024-10-31 | 2.00M shares 10-Q · filed 2026-08-14 |
| 2024-09-30 | 2.00M shares 10-Q · filed 2024-11-08 |
| 2024-06-30 | 2.00M shares 10-Q · filed 2024-08-09 |
| 2024-03-31 | 2.00M shares 10-Q · filed 2024-05-10 |
| 2023-12-31 | 2.00M shares 10-Q · filed 2026-05-15 |
| 2023-09-30 | 2.00M shares 10-Q · filed 2023-11-13 |
| 2023-06-30 | 2.00M shares 10-Q · filed 2023-08-11 |
| 2023-03-31 | 2.00M shares 10-Q · filed 2023-05-12 |
| 2022-12-31 | 2.00M shares 10-K/A · filed 2024-03-08 |
| 2022-09-30 | 2.00M shares 10-Q · filed 2022-11-14 |
| 2022-06-30 | 2.00M shares 10-Q · filed 2022-08-12 |
| 2022-03-31 | 2.00M shares 10-Q · filed 2022-05-13 |
| 2021-12-31 | 2.00M shares 10-K · filed 2023-03-14 |
| 2021-09-30 | 2.00M shares 10-Q · filed 2021-11-12 |
| 2021-06-30 | 2.00M shares 10-Q · filed 2021-08-13 |
| 2021-03-31 | 2.00M shares 10-Q · filed 2021-05-14 |
| 2020-12-31 | 2.00M shares 10-K · filed 2022-03-18 |
| 2020-12-16 | 2.00M shares 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |